Yash & Company Podcast

Colin is Chief Medical Officer of Reata Pharmaceuticals (a public biotech company: RETA). At Reata, he leads product development and strategy, clinical trial design and analysis, and medical affairs. He joined Reata in 2003 as one of its first few employees. Colin received a B.S. in chemistry with specialization in biochemistry and a B.A. in biology from the University of Virginia. He received an M.D. from the University of Texas Southwestern Medical School and an M.B.A. from Southern Methodist University Cox School of Business.